Search results for " Measurement"

showing 10 items of 2341 documents

Psychophysics, flare, and neurosecretory function in human pain models: capsaicin versus electrically evoked pain.

2007

Intradermal capsaicin injection (CAP) and electrical current stimulation (ES) are analyzed in respect to patterns and test-retest reliability of pain as well as sensory and neurosecretory changes. In 10 healthy subjects, 2 CAP (50 g) and 2 ES (5 to 30 mA) were applied to the volar forearm. The time period between 2 identical stimulations was about 4 months. Pain ratings, areas of mechanical hyperalgesia, and allodynia were assessed. The intensity of sensory changes was quantified by using quantitative sensory testing. Neurogenic flare was assessed by using laser Doppler imaging. Calcito- nin gene-related peptide (CGRP) release was quantified by dermal microdialysis in combination with an en…

AdultMaleTime FactorsSensory Receptor CellsCalcitonin Gene-Related PeptideModels NeurologicalPainStimulationSensory systemCalcitonin gene-related peptidechemistry.chemical_compoundmedicineNoxious stimulusLaser-Doppler FlowmetryPsychophysicsHumansPain MeasurementSkinNerve Fibers UnmyelinatedNeuronal Plasticitybusiness.industryNociceptorsMiddle AgedNeurosecretory SystemsElectric StimulationPeripheralAnesthesiology and Pain MedicineAllodyniaNeurologychemistryCapsaicinHyperalgesiaRegional Blood FlowAnesthesiaHyperalgesiaFemaleNeurology (clinical)medicine.symptomCapsaicinInflammation MediatorsbusinessThe journal of pain
researchProduct

Effectiveness of opioid rotation in the control of cancer pain: The ROTODOL Study

2014

Objective: To assess the effectiveness of opioid rotation (OR) to manage cancer pain. To describe the adverse events (AEs) associated with OR. Setting: Thirty-nine tertiary hospital services.Patients: Sixty-seven oncological patients with cancer-related pain treated at outpatient clinics.Intervention: Prospective multicenter study. Pain intensity was scored using a Numerical Rating Scale (NRS) of 0-10. Average pain (AP) intensity in the last 24 hours, breakthrough pain (BTP), and the number of episodes of BTP on the days before and 1 week after OR were assessed. The pre-OR and post-OR opioid were recorded. The presence and intensity of any AEs occurring after OR were also recorded.Results: …

AdultMaleTime FactorsSeverity of Illness IndexDrug Administration ScheduleTertiary Care CentersBasal (phylogenetics)AnalgèsicsRating scaleOpioid rotationNeoplasmsHumansMedicineOutpatient clinicPharmacology (medical)Prospective StudiesAdverse effectAgedPain MeasurementAged 80 and overDrug Substitutionbusiness.industryBreakthrough PainGeneral MedicineMiddle AgedIntensity (physics)Analgesics OpioidTreatment OutcomeAnesthesiology and Pain MedicineOpioidSpainAnesthesiaFemaleChronic PainOpiDolor oncològicbusinessCancer painmedicine.drugJournal of Opioid Management
researchProduct

Parafoveal versus foveal N400s dissociate spreading activation from contextual fit.

2009

Using concurrent electroencephalogram and eye movement measures to track natural reading, this study shows that N400 effects reflecting predictability are dissociable from those owing to spreading activation. In comparing predicted sentence endings with related and unrelated unpredicted endings in antonym constructions ('the opposite of black is white/yellow/nice'), fixation-related potentials at the critical word revealed a predictability-based N400 effect (unpredicted vs. predicted words). By contrast, event-related potentials time locked to the last fixation before the critical word showed an N400 only for the nonrelated unpredicted condition (nice). This effect is attributed to a parafo…

AdultMaleTime Factorsgenetic structuresmedia_common.quotation_subjectVocabularyPsycholinguisticsThinkingYoung AdultFovealContrast (vision)HumansPredictabilityEvoked PotentialsEye Movement Measurementsmedia_commonCommunicationbusiness.industryGeneral NeuroscienceEye movementBrainElectroencephalographyN400SemanticsReadingFixation (visual)FemalebusinessPsychologySentenceCognitive psychologyNeuroreport
researchProduct

Neural Mechanisms of Placebo Anxiolysis

2015

The beneficial effects of placebo treatments on fear and anxiety (placebo anxiolysis) are well known from clinical practice, and there is strong evidence indicating a contribution of treatment expectations to the efficacy of anxiolytic drugs. Although clinically highly relevant, the neural mechanisms underlying placebo anxiolysis are poorly understood. In two studies in humans, we tested whether the administration of an inactive treatment along with verbal suggestions of anxiolysis can attenuate experimentally induced states of phasic fear and/or sustained anxiety. Phasic fear is the response to a well defined threat and includes attentional focusing on the source of threat and concomitant …

AdultMaleTime Factorsmedia_common.quotation_subjectPainAnxietyElectroencephalographyPlaceboArousalPlacebosYoung AdultEvent-related potentialmedicineHumansPain Measurementmedia_commonBrain Mappingmedicine.diagnostic_testGeneral NeuroscienceBrainElectroencephalographyCognitionFearGalvanic Skin ResponseArticlesMiddle AgedPlacebo EffectElectric StimulationHealthy VolunteersAnesthesiaAnxietyFemaleCuesmedicine.symptomPsychologyNeuroscienceVigilance (psychology)Eeg alphaThe Journal of Neuroscience
researchProduct

Comparison of three methods for evaluation of work postures in a truck assembly plant

2017

International audience; This study compared the results of three risk assessment tools (self-reported questionnaire, observational tool, direct measurement method) for the upper limbs and back in a truck assembly plant at two cycle times (11 and 8 min). The weighted Kappa factor showed fair agreement between the observational and direct measurement method for the arm (0.39) and back (0.47). The weighted Kappa factor for these methods was poor for the neck (0) and wrist (0) but the observed proportional agreement (P-o) was 0.78 for the neck and 0.83 for the wrist. The weighted Kappa factor between questionnaire and direct measurement showed poor or slight agreement (0) for different body seg…

AdultMaleTruckEngineeringPostureObservationPhysical Therapy Sports Therapy and RehabilitationHuman Factors and ErgonomicsRisk management toolsdirect measurement methodRisk AssessmentObservational methodObservational method03 medical and health sciencesself-reported questionnaire0302 clinical medicineManufacturing IndustryHumans0501 psychology and cognitive sciencestruck assembly plantOccupational Health050107 human factorsSimulation[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/HealthBackMeasurement methodbusiness.industry05 social sciencesMiddle AgedWrist030210 environmental & occupational healthIndustrial engineeringMotor VehiclesWork (electrical)ArmObservational studyErgonomicsSelf Reportbusinesshuman activitiesSelf reported questionnaireNeck
researchProduct

Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain

2007

What is already known about this subject • Despite encouraging effects of N-methyl-D-aspartate (NMDA) receptor antagonists in reducing neuropathic pain of different aetiologies, the clinical use of these agents has been limited by their mainly psychotropic side-effects. • In a recent study in healthy volunteers, CNS 5161, a novel noncompetetive NMDA receptor antagonist, was well tolerated up to a dosage of 2000 µg without psychotropic side-effects. • This is the first study to evaluate the maximal tolerated dosage of CNS 5161 and to gain experience about the analgesic effect of CNS 5161 in patients with different pain syndromes. What this study adds • In patients with neuropathic pain CNS 5…

AdultMaleVisual analogue scaleAnalgesicPlaceboGuanidinesReceptors N-Methyl-D-Aspartatechemistry.chemical_compoundDrug SafetyDouble-Blind MethodMedicineHumansPharmacology (medical)Glutamate receptor antagonistSulfhydryl CompoundsAdverse effectAgedPain MeasurementPharmacologyCross-Over StudiesDose-Response Relationship Drugbusiness.industryTherapeutic effectMiddle AgedBlood pressurechemistryAnesthesiaNeuropathic painNeuralgiaFemalebusiness
researchProduct

Replacement therapy for alpha-1-protease inhibitor deficiency in PiZ subjects with chronic obstructive lung disease

1988

In a six-month multicenter feasibility and safety study, 20 patients, who all had a congenital deficiency of alpha-1-protease inhibitor (A1PI) of the PiZ phenotype accompanied by a chronic obstructive lung disease, were treated with human-plasma-derived A1PI. A weekly dose of 60 mg/kg, administered intravenously, was shown to be sufficient to maintain patient serum levels above the threshold limit of 35 percent, the serum level of healthy persons of the MZ phenotype. This is supposed to be the minimal effective level for protection against the elastolytic attack of the lung and, therefore, satisfies one of the most important criteria of feasibility of long-term replacement therapy. The glob…

AdultMalealpha 1-Antitrypsin DeficiencymedicineHumansLung Diseases ObstructiveInfusions IntravenousAgedRadial immunodiffusionClinical Trials as TopicLungPancreatic Elastasebiologybusiness.industryBlood ProteinsGeneral MedicineMiddle AgedOuchterlony double immunodiffusionTrypsinmedicine.diseaseAlpha-1 Protease Inhibitor DeficiencyObstructive lung diseasePhenotypemedicine.anatomical_structureImmunologybiology.proteinFemaleAntibodyLung Volume MeasurementsbusinessNephelometrymedicine.drugThe American Journal of Medicine
researchProduct

Improvement in altitude performance test after further acclimatization in pre-acclimatized soldiers.

2013

The Altitude Performance Test is a measure designed to assess an individual's degree of acclimatization to reduce the risk of acute mountain sickness during high-altitude activities. The aim of this study was to investigate the hypothesis that test results will improve in pre-acclimatized soldiers after several days of further acclimatization. The Altitude Performance Test consists of an uphill run at high altitude. The event is timed and performed with continuous oxygen saturation (SpO2) monitoring. The individual's time and lowest SpO2 measurement are recorded. This test was performed on the first day of arriving at 11,060 ft, and after 9 days at the same location. The 37 male soldiers we…

AdultMalebusiness.industryAcclimatizationAltitudePublic Health Environmental and Occupational HealthGeneral MedicineEffects of high altitude on humansAltitude SicknessMiddle AgedAcclimatizationAdaptation PhysiologicalTest (assessment)MountaineeringSpO2 measurementYoung AdultAnimal scienceAltitudeMilitary PersonnelMedicineHumansOximetrybusinessOxygen saturation (medicine)Military medicine
researchProduct

Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer

2004

Pain is a highly distressing symptom for patients with advanced cancer. WHO analgesic ladder is widely accepted as a guideline for its treatment. Our aim was to describe pain prevalence among patients diagnosed with advanced non-small-cell lung cancer (NSCLC), impact of pain on quality of life (QoL) and adequacy of pain management. Data of 1021 Italian patients enrolled in three randomised trials of chemotherapy for NSCLC were pooled. QoL was assessed by EORTC QLQ-C30 and LC-13. Analgesic consumption during the 3 weeks following QoL assessment was recorded. Adequacy of pain management was evaluated by the Pain Management Index (PMI). Some pain was reported by 74% of patients (42% mild, 24% …

AdultMalecancer painCancer Researchmedicine.medical_specialtyLung NeoplasmsAnalgesicPainBone NeoplasmsSeverity of Illness Indexlaw.inventionClinicalPain Management IndexRandomized controlled trialQuality of lifelawCarcinoma Non-Small-Cell LungInternal medicineEpidemiologySeverity of illnessPrevalencemedicineHumansPain ManagementAgedPain MeasurementRandomized Controlled Trials as TopicAged 80 and overbusiness.industryGuidelineanalgesicMiddle AgedClinical triallung cancerItalyOncologyanalgesicsQuality of LifePhysical therapyFemalebusinessCancer painBritish Journal of Cancer
researchProduct

Addition of a second opioid may improve opioid response in cancer pain: preliminary data

2004

Recent experimental data suggest a possible use of an opioid combination to improve analgesia. In cancer patients, a rapid opioid escalation due to either worsening of the pain condition or the development of tolerance is a critical phase, as this condition is associated with a negative prognosis. The aim of this study was to assess the effects of adding a second opioid at low doses in patients with a poor analgesic benefit after dose escalation. Fourteen patients receiving strong opioids who had increased their dosage more than 100% in the last week unsuccessfully were randomly chosen to add a second opioid to the first using an initial equivalent dosage of 20% of the previous therapy. The…

AdultMalecancer painMaximum Tolerated DosePain medicineAnalgesicPainRisk AssessmentSeverity of Illness IndexDrug Administration ScheduleStatistics Nonparametriclaw.inventionPharmacotherapyRandomized controlled triallawNeoplasmsMedicineHumansTerminally IllProspective StudiesKarnofsky Performance StatusAdverse effectAgedPain MeasurementProbabilityTerminal CareDose-Response Relationship DrugMorphinebusiness.industryMiddle AgedClinical trialAnalgesics OpioidFentanylTreatment OutcomeOncologyOpioidopioid responseAnesthesiaopioid treatmentDrug Therapy CombinationFemaleCancer painbusinessmedicine.drug
researchProduct